Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Completed
Conditions studied: Limb-Girdle Muscular Dystrophy
In brief
The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for future treatment trials based on their defined genetic classification of LGMD. In the course of this study, the investigators will perform a muscle biopsy and DNA testing in an unlimited number of patients with clinically diagnosed LGMD. The genetic testing will be extended to the family of the study subject in order to better understand true genetic defect.
Key facts
- Study ID
- NCT00457912
- Run by
- Nationwide Children's Hospital
- People needed
- 277
- Starts
- 2005-06-01
- Expected to finish
- 2018-01-01
- Last updated by the study team
- 2018-01-25
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- any subject with clinical diagnosis of LGMD
- must visit Columbus Children's Hospital for 2-day study visit
- muscle biopsy tissue must be available; either from previous biopsy, affected relative, or willing to have biopsy at Columbus Children's
You may not qualify if…
- diagnosis of a neuromuscular disorder other than LGMD
- unable to provide muscle tissue from previous or current biopsy
- incapable of giving consent and not having a legal guardian willing or able to do so
Where it is running
- Nationwide Children's Hospital — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.